drugset / Trial / NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.
Timeline
- Start
- 2024-02-21
- Primary completion
- 2027-12-03
- Completion
- 2027-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 320 ug | Inhaled |
| Background | Formoterol | Other / unclassified | 9.6 ug | Inhaled |
| Background | Glycopyrronium | Unknown | 14.4 ug | Inhaled |